```html

Lichen Planus Rash – A Complete Guide

What is Lichen planus rash?

Lichen planus (LP) is an inflammatory, non‑infectious skin condition that presents most often as an itchy, flat‑topped, purplish‑red rash. The name comes from the Greek word lichen (“moss”) and the Latin word planus (“flat”), describing the characteristic appearance of the lesions. Though the skin is the most common site, LP can affect the mucous membranes (mouth, genitals), nails, and even the scalp. The exact cause remains unknown, but the disease is believed to be an autoimmune reaction in which the body’s immune system mistakenly attacks basal keratinocytes (skin cells) in the epidermis.

LP most frequently appears in adults aged 30‑60 years and is slightly more common in women. It is not contagious and does not spread through contact.

Common Causes

While the precise trigger for lichen planus is still under investigation, several factors have been linked to its onset. Below are the most frequently reported associations:

• Autoimmune dysfunction: The immune system’s misdirected attack on skin cells is the core mechanism.
• Medications: Certain drugs can induce a “drug‑triggered” LP, including:
  • Beta‑blockers (e.g., propranolol)
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs)
  • ACE inhibitors
  • Antimalarials (chloroquine, hydroxychloroquine)
  • Thiazide diuretics
• Viral infections: Hepatitis C infection has a well‑documented association, especially with oral LP.<sup>1</sup>
• Dental materials: Allergic reactions to dental amalgam or other metal fillings may precipitate oral LP.
• Contact allergens: Nickel, fragrances, or certain topical agents can trigger a localized form.
• Genetic predisposition: Family clustering suggests a hereditary component, though no single gene has been identified.
• Stress: Psychological stress can exacerbate immune dysregulation and precipitate flare‑ups.
• Other autoimmune diseases: Conditions such as vitiligo, thyroiditis, or lupus may coexist with LP.
• Cutaneous trauma (Koebner phenomenon): New lesions may develop at sites of scratching, pressure, or surgical scars.

Associated Symptoms

LP does not occur in isolation. Patients often report one or more of the following accompanying features:

• Intense itching (pruritus): Often the most bothersome symptom, worsening at night.
• Burning or stinging sensation: Particularly when lesions are in moist areas.
• Mucosal involvement: White, lacy patches (Wickham’s striae) on the tongue, gums, or genital mucosa; may cause soreness when eating or urinating.
• Nail changes: Thinning, ridging, splitting, or complete loss of the nail plate.
• Hair loss (lichen planopilaris): Scarring alopecia on the scalp.
• Secondary infection: Scratching can break the skin, allowing bacterial colonization.

When to See a Doctor

Most cases of lichen planus can be managed by a dermatologist, but prompt medical attention is advisable when any of the following occur:

• The rash spreads rapidly or involves large body areas.
• Severe itching interferes with sleep or daily activities.
• Oral or genital lesions cause painful swallowing, eating, or urination.
• There is noticeable nail deformation, thinning, or loss.
• Lesions become crusted, ooze pus, or show signs of infection.
• You have a known hepatitis C infection or other chronic disease that may affect treatment choices.
• Symptoms persist for more than 6–8 weeks without improvement.

Early evaluation helps prevent complications such as permanent scarring, nail loss, or malignant transformation of oral lesions (rare but reported).

Diagnosis

Diagnosing lichen planus is primarily clinical, but physicians often use additional tools to confirm the diagnosis and rule out mimickers.

Clinical examination

• Characteristic “polygonal, flat‑topped, violaceous papules” with fine white lines (Wickham’s striae).
• Distribution patterns: wrists, forearms, lower back, ankles, and oral mucosa.
• Koebner phenomenon: new lesions at sites of trauma.

Skin biopsy

In atypical cases, a 4‑mm punch biopsy is performed. Histology typically shows:

• Band‑like lymphocytic infiltrate at the dermal‑epidermal junction.
• Degeneration of basal keratinocytes (lichenoid interface dermatitis).
• Colloid bodies (Civatte bodies) within the epidermis.

Additional tests

• Serology for hepatitis C: Recommended for all patients with oral LP or unexplained LP.<sup>2</sup>
• Patch testing: If a contact allergen is suspected.
• Blood work: CBC, liver function, and thyroid panel if autoimmune overlap is considered.

Treatment Options

Treatment aims to reduce itching, limit spread, and minimize scarring. Management is individualized based on severity, location, and patient comorbidities.

Topical Therapies

• High‑potency corticosteroids: Clobetasol 0.05% ointment applied twice daily for 2–4 weeks is first‑line for skin lesions.
• Calcineurin inhibitors: Tacrolimus 0.1% or pimecrolimus 1% cream for sensitive areas (face, groin) where steroids may cause thinning.
• Topical retinoids: Tazarotene 0.05% can be used for hyperkeratotic plaques but may increase irritation.

Systemic Medications

• Oral corticosteroids: Short courses (e.g., prednisone 0.5 mg/kg) for severe, widespread disease.
• Antihistamines: Non‑sedating agents (cetirizine, loratadine) help control pruritus.
• Immunosuppressants: Azathioprine or mycophenolate mofetil in refractory cases.
• Retinoids: Acitretin (25‑35 mg daily) for extensive or resistant cutaneous LP.
• Biologics: Emerging data support low‑dose oral tacrolimus or the IL‑17 inhibitor secukinumab for chronic, recalcitrant disease.

Procedural Options

• Phototherapy: Narrow‑band UVB 3‑5 times per week can improve widespread lesions.
• Laser therapy: CO₂ laser or pulsed dye laser for isolated, stubborn plaques.
• Intralesional steroids: Triamcinolone acetonide injection for thick, hypertrophic plaques.

Home & Lifestyle Measures

• Apply cool compresses for 10‑15 minutes to relieve itching.
• Use fragrance‑free moisturizers (e.g., petrolatum, ceramide‑rich creams) at least twice daily.
• Avoid hot showers and harsh soaps that can aggravate lesions.
• Keep nails trimmed to reduce skin damage from scratching.
• Identify and avoid known triggers (e.g., specific medications, dental amalgam).
• Practice stress‑reduction techniques—mindfulness, yoga, or counseling—because stress can worsen LP.

Prevention Tips

Because the exact cause of lichen planus is not fully understood, prevention focuses on minimizing known triggers and supporting overall skin health:

• Medication review: Discuss all prescription and over‑the‑counter drugs with your physician; consider alternatives if a drug‑induced rash is suspected.
• Dental care: Replace amalgam fillings with composite materials if you have oral LP or known metal sensitivity.
• Sun protection: Use broad‑spectrum sunscreen (SPF 30+) daily; UV exposure can occasionally exacerbate lesions.
• Skin hygiene: Gentle cleansing, prompt drying, and regular emollient use keep the barrier intact.
• Avoid trauma: Wear loose clothing, avoid prolonged pressure, and treat scratches promptly.
• Screen for hepatitis C: If you have risk factors (IV drug use, blood transfusions before 1992), get tested; early treatment of hepatitis C may reduce LP incidence.

Emergency Warning Signs

References

1. Mayo Clinic. “Lichen planus.” Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “Hepatitis C and Lichen Planus.” 2022. https://www.cdc.gov
3. National Institutes of Health. “Lichen Planus Fact Sheet.” 2021. https://www.niams.nih.gov
4. Cleveland Clinic. “Lichen Planus Treatment Options.” 2023. https://my.clevelandclinic.org
5. World Health Organization. “Guidelines on the Management of Viral Hepatitis.” 2022.

```